Secondary Logo

Journal Logo

October 2010 - Volume 33 - Issue 8
pp: 743-924

Preclinical Qualification of a New Multi-antigen Candidate Vaccine for Metastatic Melanoma

Vogel, Thorsten U.; Visan, Lucian; Ljutic, Belma; More

Journal of Immunotherapy. 33(8):743-758, October 2010.

Adjuvant Therapy With Agonistic Antibodies to CD134 (OX40) Increases Local Control After Surgical or Radiation Therapy of Cancer in Mice

Gough, Michael J.; Crittenden, Marka R.; Sarff, MaryClare; More

Journal of Immunotherapy. 33(8):798-809, October 2010.

CD40 Expression by Human Melanocytic Lesions and Melanoma Cell Lines and Direct CD40 Targeting With the Therapeutic Anti-CD40 Antibody CP-870,893

Kalbasi, Anusha; Fonsatti, Ester; Natali, Pier Giorgio; More

Journal of Immunotherapy. 33(8):810-816, October 2010.


Changes in Dendritic Cell Phenotype After a New High-dose Weekly Schedule of Interleukin-2 Therapy for Kidney Cancer and Melanoma

Finkelstein, Steven E.; Carey, Timothy; Fricke, Ingo; More

Journal of Immunotherapy. 33(8):817-827, October 2010.

Memory and Effector CD8 T-cell Responses After Nanoparticle Vaccination of Melanoma Patients

Speiser, Daniel E.; Schwarz, Katrin; Baumgaertner, Petra; More

Journal of Immunotherapy. 33(8):848-858, October 2010.



PDF Only